Daniel J. Hicklin
2020
In 2020, Daniel J. Hicklin earned a total compensation of $3M as President and Chief Executive Officer at Werewolf Therapeutics.
Compensation breakdown
Bonus | $193,936 |
---|---|
Option Awards | $2,370,987 |
Salary | $425,000 |
Total | $2,989,923 |
Hicklin received $2.4M in option awards, accounting for 79% of the total pay in 2020.
Hicklin also received $193.9K in bonus and $425K in salary.
Rankings
In 2020, Daniel J. Hicklin's compensation ranked 3,855th out of 13,090 executives tracked by ExecPay. In other words, Hicklin earned more than 70.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,855 out of 13,090 | 71st |
Division Manufacturing | 1,534 out of 5,624 | 73rd |
Major group Chemicals And Allied Products | 580 out of 2,257 | 74th |
Industry group Drugs | 499 out of 1,957 | 75th |
Industry Pharmaceutical Preparations | 377 out of 1,462 | 74th |
Source: SEC filing on April 22, 2022.